Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Cutting Edge All-in-One Equipment Can Turn 600 Square Feet Room into COVID-19 Testing Lab

By LabMedica International staff writers
Posted on 26 Oct 2020
Vessel Medical (Greenville, SC, USA) has introduced Lab in a Box which comprises cutting edge all-in-one equipment that can turn a 600 square feet room into a COVID-19 testing lab.

Developed by scientists and technicians in partnership with Hamilton Company, Thermo Fisher, Grenova, and Premier Medical Laboratory Services, Lab in a Box enables a high capacity of onsite diagnostics for hospitals, expanding laboratories, schools, and large companies in need of quick and accurate testing results. The turnkey equipment that includes everything needed for professional laboratory level diagnostic is expected to radically change the landscape of COVID-19 testing. Each turnkey lab solution includes the latest cutting edge technology that is pre-validated - all that is required is a brief onsite validation before testing can begin. With precision robotic instruments, Lab in a Box has high throughput liquid handling along with automated, custom-programmable pipetting that decreases human error and result turnaround time. Additionally, Vessel Medical’s Laboratory Information System (LIS) that is included reduces the result analysis time while increasing capacity exponentially. The key features of Lab in a Box help companies to begin testing and to maintain a testing flow uninterrupted.

Aside from COVID-19 assays, companies, expanding labs, and organizations can easily pivot their workflow to include detection of other common pathogens as well as genetic testing with upper respiratory, antibiotic resistance, pharmacogenomics, cancer risk screening, Flu A & B, and Std/UTI assays. Vessel Medical expects in-house testing with its Lab in a Box to allow companies to save millions of dollars annually in testing expenses. For example, a company that processes 3,000 tests per day can save just under USD 200,000 per day when compared to outsourced testing, while companies that process 12,000 tests per day can save up to USD 600,000 per day with its turnkey equipment.

“We developed Lab in a Box with the goal of providing the most efficient solution for companies and organizations to provide quality COVID-19 testing,” said Kevin Murdock, Founder of Vessel Medical. “This equipment conveniently provides the most cutting edge technology for accurate testing while saving time and money. We’re happy to help protect businesses, organizations and the people who work for them.”

Related Links:
Vessel Medical


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
High Performance Centrifuge
CO336/336R
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.